Skip to content

Abnormal Circulating Vldl C Concentration C4703601

Published: July 22, 2026Updated: August 20, 2026

Abnormal VLDL cholesterol levels may increase heart disease risk. It often relates to diet, metabolism, or genetic factors. Treatment focuses on lifestyle changes and medication.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Acute pancreatitis

Severe inflammation of the pancreas causing intense abdominal pain, nausea, and vomiting due to extremely high triglyceride levels.

Seek immediate medical attention if experiencing severe persistent abdominal pain, vomiting, or fever, as pancreatitis can be life-threatening.

Fatigue

(constitutional)

Persistent tiredness and lack of energy due to impaired lipid metabolism affecting cellular energy production.

Frequency: 60-70% of patients

Abdominal discomfort

(gastrointestinal)

Mild to moderate abdominal pain or fullness, often in the upper abdomen, related to hepatomegaly and altered digestion.

Frequency: 40-50% of patients

Eruptive xanthomas

(dermatologic)

Small, yellow-orange papules on the skin, particularly on the buttocks, thighs, and elbows, caused by lipid deposits.

Frequency: 10-20% of patients

Lipemia retinalis

(ocular)

Creamy-white appearance of retinal blood vessels due to high lipid content in the blood, detected on eye examination.

Frequency: 5-10% of patients

Peripheral edema

(cardiovascular)

Swelling in the legs and ankles due to altered lipid metabolism affecting circulation and blood vessel integrity.

Frequency: 30-40% of patients

Hepatomegaly

(gastrointestinal)

Enlarged liver due to fatty infiltration and impaired lipid processing, often detectable on physical examination.

Frequency: 15-25% of patients

Cognitive difficulty

(neurologic)

Mild memory issues or difficulty concentrating associated with chronic dyslipidemia affecting cerebral blood flow.

Frequency: 5-8% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Aerobic exercise program

Regular cardiovascular exercise including walking, cycling, or swimming to reduce VLDL particle production and improve lipid metabolism. Treatment approach lowers triglycerides through enhanced lipoprotein lipase activity.

lifestyle
2

Exercise prescription and weight management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Low-fat and refined carbohydrate restriction

Dietary modification reducing saturated fats and eliminating refined sugars and simple carbohydrates that contribute to VLDL overproduction. Treatment approach addresses metabolic drivers of elevated VLDL.

dietary

Additional treatment options

Lipid-lowering pharmacotherapy

Fibrate, niacin, or omega-3 fatty acid medications to reduce VLDL production and enhance clearance. Treatment approach used when lifestyle modifications alone are insufficient.

medication

Weight management program

Structured weight loss program targeting reduction in visceral adiposity which drives VLDL overproduction. Treatment approach improves insulin sensitivity and reduces hepatic triglyceride synthesis.

lifestyle

Lipid profile surveillance

Regular monitoring of fasting lipid panels including VLDL cholesterol estimation and triglyceride levels. Treatment approach tracks response to interventions and guides treatment adjustments.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Circulating Vldl C Concentration C4703601?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC Guideline on the Management of Blood Cholesterol. Circulation. 2019;139:e1082–e1143.

guideline2019View source →
2

Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111-188.

guideline2020View source →
3

National Lipid Association. Recommendations for Patient-Centered Management of Dyslipidemia: Part 1 - Full Report. J Clin Lipidol. 2020;14(2):129-169.

position_statement2020View source →
4

Feingold KR. Triglyceride Metabolism. [Updated 2022]. In: Feingold KR, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.

review2022View source →
5

Toth PP, Thanassoulis G, Williams K, et al. The National Lipid Association 2022 Dyslipidemia Practice Guidelines: What Is New and What To Expect. J Clin Lipidol. 2022;16(5):573-585.

review2022View source →
6

Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J, editors. Harrison's Principles of Internal Medicine, 21st edition. New York: McGraw-Hill; 2022.

textbook2022
7

Centers for Disease Control and Prevention (CDC). Cholesterol Types. Updated 2024. https://www.cdc.gov/cholesterol/about.html

8

Expert Consensus Panel on Hypertriglyceridemia. Management of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2021;106(10):2999-3021.

consensus2021View source →
9

AIM-HIGH Investigators. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med. 2011;365(24):2255-2267.

clinical_trial2011View source →
10

Liu J, Zeng FF, Liu ZM, et al. Effects of fish oil on circulating lipoprotein(a) and triglycerides: a systematic review and meta-analysis of randomized controlled trials. Food Funct. 2021;12(20):9398-9414.

review2021View source →

Medication Comparisons

Compare medications used to treat Abnormal Circulating Vldl C Concentration C4703601. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy